{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:53:16Z","timestamp":1790790796630,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Heidelberg der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Ment Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Psilocybin-assisted therapies are innovative therapeutic approaches, particularly in the treatment of depression. However, there are sparse studies providing functional magnetic resonance imaging (fMRI) evidence elucidating the underlying biological mechanisms that support clinical outcomes. This review aims to comprehensively gather all the evidence reported in psilocybin studies using fMRI techniques. Independent extraction of articles was conducted by 2 authors using predefined data fields. 20 unique datasets were identified, with 5 including participants diagnosed with depression. Dropout rates were found to be high, and follow-up scanning timepoints were lacking in most of the studies. Most research has focused on the amygdala, the anterior cingulate cortex and the prefrontal cortex, as key regions involved in the effects of psilocybin. However, the current literature exhibits inconsistency in methods and designs. Further research is necessary to better define psilocybin\u2019s impact on the human brain and its potential to enhance psychotherapy outcomes.<\/jats:p>","DOI":"10.1007\/s44192-026-00384-w","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:35:09Z","timestamp":1773930909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies"],"prefix":"10.1007","volume":"6","author":[{"given":"\u00c0lvar","family":"Farr\u00e9-Colom\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Rublinetska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Soto-Angona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"2","key":"384_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE. Psychedelics. Pharmacol Rev. 2016;68(2):264\u2013355.","journal-title":"Pharmacol Rev"},{"issue":"1 & 2","key":"384_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1615\/IntJMedMushr.v7.i12.280","volume":"7","author":"G Guzm\u00e1n","year":"2005","unstructured":"Guzm\u00e1n G. Species diversity of the genus Psilocybe (Basidiomycotina, Agaricales, Strophariaceae) in the world mycobiota, with special attention to hallucinogenic properties. Int J Med Mushrooms. 2005;7(1 & 2):305\u201332.","journal-title":"Int J Med Mushrooms"},{"issue":"3","key":"384_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, et al. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol. 2015;29(3):289\u201399.","journal-title":"J Psychopharmacol"},{"issue":"10","key":"384_CR4","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3390\/molecules26102948","volume":"26","author":"H Lowe","year":"2021","unstructured":"Lowe H, et al. The therapeutic potential of psilocybin. Molecules. 2021;26(10):2948.","journal-title":"Molecules"},{"key":"384_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.735523","volume":"12","author":"MJ Spriggs","year":"2021","unstructured":"Spriggs MJ, et al. Study protocol for \u201cPsilocybin as a treatment for anorexia nervosa: a pilot study.\u201d Front Psych. 2021;12:735523.","journal-title":"Front Psych"},{"issue":"15","key":"384_CR6","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","volume":"384","author":"R Carhart-Harris","year":"2021","unstructured":"Carhart-Harris R, et al. Trial of psilocybin versus escitalopram for depression. N Engl J Med. 2021;384(15):1402\u201311.","journal-title":"N Engl J Med"},{"issue":"2","key":"384_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/02698811211073759","volume":"36","author":"N Gukasyan","year":"2022","unstructured":"Gukasyan N, et al. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up. J Psychopharmacol. 2022;36(2):151\u20138.","journal-title":"J Psychopharmacol"},{"issue":"18","key":"384_CR8","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin GM, et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med. 2022;387(18):1637\u201348.","journal-title":"N Engl J Med"},{"issue":"4","key":"384_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/1355621021000005937","volume":"7","author":"T Passie","year":"2002","unstructured":"Passie T, et al. The pharmacology of psilocybin. Addict Biol. 2002;7(4):357\u201364.","journal-title":"Addict Biol"},{"issue":"1","key":"384_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40263-021-00877-y","volume":"36","author":"S Ling","year":"2022","unstructured":"Ling S, et al. Molecular mechanisms of psilocybin and implications for the treatment of depression. CNS Drugs. 2022;36(1):17\u201330.","journal-title":"CNS Drugs"},{"issue":"9","key":"384_CR11","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1038\/s41380-023-02274-x","volume":"28","author":"AM Jaster","year":"2023","unstructured":"Jaster AM, Gonzalez-Maeso J. Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics. Mol Psychiatry. 2023;28(9):3595\u2013612.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"384_CR12","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","volume":"44","author":"MK Madsen","year":"2019","unstructured":"Madsen MK, et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacol. 2019;44(7):1328\u201334.","journal-title":"Neuropsychopharmacol."},{"issue":"6","key":"384_CR13","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/sj.npp.1300621","volume":"30","author":"OL Carter","year":"2005","unstructured":"Carter OL, et al. Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. Neuropsychopharmacol. 2005;30(6):1154\u201362.","journal-title":"Neuropsychopharmacol."},{"issue":"4","key":"384_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.euroneuro.2016.01.005","volume":"26","author":"T Pokorny","year":"2016","unstructured":"Pokorny T, et al. Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A\/2A agonist ergotamine on psilocybin-induced psychedelic experience. Eur Neuropsychopharmacol. 2016;26(4):756\u201366.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"11","key":"384_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","volume":"21","author":"FX Vollenweider","year":"2020","unstructured":"Vollenweider FX, Preller KH. Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. Nat Rev Neurosci. 2020;21(11):611\u201324.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"384_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/pr.118.017160","volume":"71","author":"RL Carhart-Harris","year":"2019","unstructured":"Carhart-Harris RL, Friston KJ. REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev. 2019;71(3):316\u201344.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"384_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","volume":"26","author":"JJ Gattuso","year":"2023","unstructured":"Gattuso JJ, et al. Default mode network modulation by psychedelics: A systematic review. Int J Neuropsychopharmacol. 2023;26(3):155\u201388.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"384_CR18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","volume":"11","author":"MK Doss","year":"2021","unstructured":"Doss MK, et al. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Transl Psychiatry. 2021;11(1):574.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"384_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","volume":"177","author":"CM Reiff","year":"2020","unstructured":"Reiff CM, et al. Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry. 2020;177(5):391\u2013410.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"384_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","volume":"11","author":"RG Dos Santos","year":"2018","unstructured":"Dos Santos RG, et al. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Rev Clin Pharmacol. 2018;11(9):889\u2013902.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"384_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104689","volume":"138","author":"DE McCulloch","year":"2022","unstructured":"McCulloch DE, et al. Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses. Neurosci Biobehav Rev. 2022;138:104689.","journal-title":"Neurosci Biobehav Rev"},{"key":"384_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neubiorev.2016.10.026","volume":"71","author":"RG Dos Santos","year":"2016","unstructured":"Dos Santos RG, et al. Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging. Neurosci Biobehav Rev. 2016;71:715\u201328.","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"384_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.","journal-title":"PLoS Med"},{"key":"384_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.neubiorev.2021.02.016","volume":"124","author":"J Radua","year":"2021","unstructured":"Radua J. PRISMA 2020 - An updated checklist for systematic reviews and meta-analyses. Neurosci Biobehav Rev. 2021;124:324\u20135.","journal-title":"Neurosci Biobehav Rev"},{"key":"384_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.116980","volume":"218","author":"FS Barrett","year":"2020","unstructured":"Barrett FS, et al. Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention. Neuroimage. 2020;218:116980.","journal-title":"Neuroimage"},{"key":"384_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119434","volume":"260","author":"A Gaddis","year":"2022","unstructured":"Gaddis A, et al. Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity. Neuroimage. 2022;260:119434.","journal-title":"Neuroimage"},{"key":"384_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","volume":"196","author":"L Smigielski","year":"2019","unstructured":"Smigielski L, et al. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. Neuroimage. 2019;196:207\u201315.","journal-title":"Neuroimage"},{"issue":"1","key":"384_CR28","doi-asserted-by":"publisher","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","volume":"7","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris RL, et al. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Sci Rep. 2017;7(1):13187.","journal-title":"Sci Rep"},{"key":"384_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","volume":"142","author":"L Roseman","year":"2018","unstructured":"Roseman L, et al. Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology. 2018;142:263\u20139.","journal-title":"Neuropharmacology"},{"issue":"4","key":"384_CR30","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","volume":"28","author":"RE Daws","year":"2022","unstructured":"Daws RE, et al. Increased global integration in the brain after psilocybin therapy for depression. Nat Med. 2022;28(4):844\u201351.","journal-title":"Nat Med"},{"issue":"18","key":"384_CR31","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1073\/pnas.1524187113","volume":"113","author":"KH Preller","year":"2016","unstructured":"Preller KH, et al. Effects of serotonin 2A\/1A receptor stimulation on social exclusion processing. Proc Natl Acad Sci U S A. 2016;113(18):5119\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"384_CR32","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1002\/hbm.22833","volume":"36","author":"AV Lebedev","year":"2015","unstructured":"Lebedev AV, et al. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin. Hum Brain Mapp. 2015;36(8):3137\u201353.","journal-title":"Hum Brain Mapp"},{"key":"384_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuroimage.2019.05.060","volume":"199","author":"LD Lord","year":"2019","unstructured":"Lord LD, et al. Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin. Neuroimage. 2019;199:127\u201342.","journal-title":"Neuroimage"},{"key":"384_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119220","volume":"256","author":"M Girn","year":"2022","unstructured":"Girn M, et al. Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex. Neuroimage. 2022;256:119220.","journal-title":"Neuroimage"},{"key":"384_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119716","volume":"264","author":"AS Olsen","year":"2022","unstructured":"Olsen AS, et al. Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects. Neuroimage. 2022;264:119716.","journal-title":"Neuroimage"},{"issue":"2","key":"384_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/sj.npp.1301412","volume":"33","author":"GJ Dowling","year":"2008","unstructured":"Dowling GJ, Weiss SR, Condon TP. Drugs of abuse and the aging brain. Neuropsychopharmacol. 2008;33(2):209\u201318.","journal-title":"Neuropsychopharmacol."},{"issue":"21","key":"384_CR37","doi-asserted-by":"publisher","first-page":"8174","DOI":"10.1073\/pnas.0402680101","volume":"101","author":"N Gogtay","year":"2004","unstructured":"Gogtay N, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA. 2004;101(21):8174\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"384_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.npp.1301553","volume":"33","author":"JL Rapoport","year":"2008","unstructured":"Rapoport JL, Gogtay N. Brain neuroplasticity in healthy, hyperactive and psychotic children: insights from neuroimaging. Neuropsychopharmacol. 2008;33(1):181\u201397.","journal-title":"Neuropsychopharmacol."},{"issue":"6","key":"384_CR39","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1073\/pnas.1119598109","volume":"109","author":"RL Carhart-Harris","year":"2012","unstructured":"Carhart-Harris RL, et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci USA. 2012;109(6):2138\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"384_CR40","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1002\/hbm.22562","volume":"35","author":"E Tagliazucchi","year":"2014","unstructured":"Tagliazucchi E, et al. Enhanced repertoire of brain dynamical states during the psychedelic experience. Hum Brain Mapp. 2014;35(11):5442\u201356.","journal-title":"Hum Brain Mapp"},{"issue":"8","key":"384_CR41","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","volume":"78","author":"R Kraehenmann","year":"2015","unstructured":"Kraehenmann R, et al. Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biol Psychiatry. 2015;78(8):572\u201381.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"384_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41398-021-01335-5","volume":"11","author":"NL Mason","year":"2021","unstructured":"Mason NL, et al. Spontaneous and deliberate creative cognition during and after psilocybin exposure. Transl Psychiatry. 2021;11(1):209.","journal-title":"Transl Psychiatry"},{"key":"384_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.euroneuro.2021.06.001","volume":"50","author":"MK Madsen","year":"2021","unstructured":"Madsen MK, et al. Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience. Eur Neuropsychopharmacol. 2021;50:121\u201332.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"384_CR44","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","volume":"10","author":"FS Barrett","year":"2020","unstructured":"Barrett FS, et al. Emotions and brain function are altered up to one month after a single high dose of psilocybin. Sci Rep. 2020;10(1):2214.","journal-title":"Sci Rep"},{"issue":"8023","key":"384_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","volume":"632","author":"JS Siegel","year":"2024","unstructured":"Siegel JS, et al. Psilocybin desynchronizes the human brain. Nature. 2024;632(8023):131\u20138.","journal-title":"Nature"},{"issue":"1","key":"384_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/02698811211026454","volume":"36","author":"DE McCulloch","year":"2022","unstructured":"McCulloch DE, et al. Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals. J Psychopharmacol. 2022;36(1):74\u201384.","journal-title":"J Psychopharmacol"},{"issue":"18","key":"384_CR47","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMe2210975","volume":"387","author":"B Madras","year":"2022","unstructured":"Madras B. Psilocybin in treatment-resistant depression. N Engl J Med. 2022;387(18):1708\u20139.","journal-title":"N Engl J Med"},{"issue":"9","key":"384_CR48","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJMc2109725","volume":"385","author":"J Wiley","year":"2021","unstructured":"Wiley J, et al. Psilocybin for depression. N Engl J Med. 2021;385(9):860\u20132.","journal-title":"N Engl J Med"},{"issue":"10","key":"384_CR49","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1007\/s00213-022-06221-6","volume":"239","author":"M Butler","year":"2022","unstructured":"Butler M, Jelen L, Rucker J. Expectancy in placebo-controlled trials of psychedelics: If so, so what? Psychopharmacology. 2022;239(10):3047\u201355.","journal-title":"Psychopharmacology"},{"key":"384_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117164","volume":"221","author":"D Szucs","year":"2020","unstructured":"Szucs D, Ioannidis JP. Sample size evolution in neuroimaging research: an evaluation of highly-cited studies (1990\u20132012) and of latest practices (2017\u20132018) in high-impact journals. Neuroimage. 2020;221:117164.","journal-title":"Neuroimage"},{"key":"384_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.nicl.2015.08.009","volume":"11","author":"R Kraehenmann","year":"2016","unstructured":"Kraehenmann R, et al. The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. Neuroimage Clin. 2016;11:53\u201360.","journal-title":"Neuroimage Clin"},{"issue":"4","key":"384_CR52","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.neuroimage.2012.04.018","volume":"61","author":"K Friston","year":"2012","unstructured":"Friston K. Ten ironic rules for non-statistical reviewers. Neuroimage. 2012;61(4):1300\u201310.","journal-title":"Neuroimage"},{"issue":"6","key":"384_CR53","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.euroneuro.2018.03.016","volume":"28","author":"O Grimm","year":"2018","unstructured":"Grimm O, et al. Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination. Eur Neuropsychopharmacol. 2018;28(6):691\u2013700.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"384_CR54","doi-asserted-by":"publisher","first-page":"e1084","DOI":"10.1038\/tp.2017.54","volume":"7","author":"F Mueller","year":"2017","unstructured":"Mueller F, et al. Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects. Transl Psychiatry. 2017;7(4):e1084.","journal-title":"Transl Psychiatry"},{"key":"384_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117430","author":"T Arruda Sanchez","year":"2024","unstructured":"Arruda Sanchez T, et al. Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: an fMRI study. J Ethnopharmacol. 2024. https:\/\/doi.org\/10.1016\/j.jep.2023.117430.","journal-title":"J Ethnopharmacol"},{"key":"384_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.739053","volume":"12","author":"J Castelhano","year":"2021","unstructured":"Castelhano J, et al. The effects of tryptamine psychedelics in the brain: a meta-analysis of functional and review of molecular imaging studies. Front Pharmacol. 2021;12:739053.","journal-title":"Front Pharmacol"},{"issue":"6","key":"384_CR57","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1192\/bjp.bp.108.056093","volume":"194","author":"SE Murphy","year":"2009","unstructured":"Murphy SE, et al. Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry. 2009;194(6):535\u201340.","journal-title":"Br J Psychiatry"},{"issue":"12","key":"384_CR58","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1017\/S0033291712000591","volume":"42","author":"BR Godlewska","year":"2012","unstructured":"Godlewska BR, et al. Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients. Psychol Med. 2012;42(12):2609\u201317.","journal-title":"Psychol Med"},{"key":"384_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2023.111777","volume":"338","author":"VK Tassone","year":"2024","unstructured":"Tassone VK, et al. Amygdala biomarkers of treatment response in major depressive disorder: An fMRI systematic review of SSRI antidepressants. Psychiatry Res Neuroimaging. 2024;338:111777.","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"8","key":"384_CR60","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrn3027","volume":"12","author":"SG Disner","year":"2011","unstructured":"Disner SG, et al. Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci. 2011;12(8):467\u201377.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"384_CR61","first-page":"361","volume":"8","author":"A Zavaliangos-Petropulu","year":"2023","unstructured":"Zavaliangos-Petropulu A, et al. Neuroimaging-derived biomarkers of the antidepressant effects of ketamine. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023;8(4):361\u201386.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"1","key":"384_CR62","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1073\/pnas.012470999","volume":"99","author":"G Bush","year":"2002","unstructured":"Bush G, et al. Dorsal anterior cingulate cortex: a role in reward-based decision making. Proc Natl Acad Sci U S A. 2002;99(1):523\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"384_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fnbeh.2016.00064","volume":"10","author":"K Dedovic","year":"2016","unstructured":"Dedovic K, et al. Dorsal anterior cingulate cortex responses to repeated social evaluative feedback in young women with and without a history of depression. Front Behav Neurosci. 2016;10:64.","journal-title":"Front Behav Neurosci"},{"issue":"5643","key":"384_CR64","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.1089134","volume":"302","author":"NI Eisenberger","year":"2003","unstructured":"Eisenberger NI, Lieberman MD, Williams KD. Does rejection hurt? An FMRI study of social exclusion. Science. 2003;302(5643):290\u20132.","journal-title":"Science"},{"issue":"3","key":"384_CR65","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.neubiorev.2013.01.002","volume":"37","author":"PG Gasquoine","year":"2013","unstructured":"Gasquoine PG. Localization of function in anterior cingulate cortex: from psychosurgery to functional neuroimaging. Neurosci Biobehav Rev. 2013;37(3):340\u20138.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"384_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/scan\/nsu110","volume":"10","author":"JY Rotge","year":"2015","unstructured":"Rotge JY, et al. A meta-analysis of the anterior cingulate contribution to social pain. Soc Cogn Affect Neurosci. 2015;10(1):19\u201327.","journal-title":"Soc Cogn Affect Neurosci"},{"issue":"2","key":"384_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118143","volume":"10","author":"F Palhano-Fontes","year":"2015","unstructured":"Palhano-Fontes F, et al. The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PLoS One. 2015;10(2): e0118143.","journal-title":"PLoS One"},{"issue":"6","key":"384_CR68","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/0269881120909409","volume":"34","author":"L Pasquini","year":"2020","unstructured":"Pasquini L, Palhano-Fontes F, Araujo DB. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks. J Psychopharmacol (Oxf). 2020;34(6):623\u201335.","journal-title":"J Psychopharmacol (Oxf)"},{"issue":"9","key":"384_CR69","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ijnp\/pyx036","volume":"20","author":"F Sampedro","year":"2017","unstructured":"Sampedro F, et al. Assessing the psychedelic \u201cafter-glow\u201d in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. Int J Neuropsychopharmacol. 2017;20(9):698\u2013711.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"10","key":"384_CR70","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1017\/S0033291720000434","volume":"51","author":"X Peng","year":"2021","unstructured":"Peng X, et al. Sub-regional anterior cingulate cortex functional connectivity revealed default network subsystem dysfunction in patients with major depressive disorder. Psychol Med. 2021;51(10):1687\u201395.","journal-title":"Psychol Med"},{"key":"384_CR71","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.nicl.2018.03.005","volume":"18","author":"F M\u00fcller","year":"2018","unstructured":"M\u00fcller F, et al. Altered network hub connectivity after acute LSD administration. Neuroimage Clin. 2018;18:694\u2013701.","journal-title":"Neuroimage Clin"},{"issue":"17","key":"384_CR72","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","volume":"113","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci U S A. 2016;113(17):4853\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"384_CR73","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1162\/netn_a_00349","volume":"8","author":"HM Tolle","year":"2024","unstructured":"Tolle HM, et al. The unique neural signature of your trip: functional connectome fingerprints of subjective psilocybin experience. Netw Neurosci. 2024;8(1):203\u201325.","journal-title":"Netw Neurosci"},{"issue":"2","key":"384_CR74","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/0269881119895520","volume":"34","author":"LJ Mertens","year":"2020","unstructured":"Mertens LJ, et al. Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. J Psychopharmacol. 2020;34(2):167\u201380.","journal-title":"J Psychopharmacol"},{"issue":"6","key":"384_CR75","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","volume":"72","author":"RH Kaiser","year":"2015","unstructured":"Kaiser RH, et al. Large-scale network dysfunction in major depressive disorder: A meta-analysis of resting-state functional connectivity. JAMA Psychiat. 2015;72(6):603\u201311.","journal-title":"JAMA Psychiat"},{"issue":"33","key":"384_CR76","doi-asserted-by":"publisher","first-page":"8877","DOI":"10.1523\/JNEUROSCI.2063-07.2007","volume":"27","author":"T Johnstone","year":"2007","unstructured":"Johnstone T, et al. Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J Neurosci. 2007;27(33):8877\u201384.","journal-title":"J Neurosci"},{"key":"384_CR77","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jad.2023.04.081","volume":"333","author":"BM Wall","year":"2023","unstructured":"Wall BM, et al. Increased low-frequency brain responses to music after psilocybin therapy for depression. J Affect Disord. 2023;333:321\u201330.","journal-title":"J Affect Disord"},{"key":"384_CR78","unstructured":"Gazzaniga, M.S., R.B. Ivry, and G.R. Mangun.\u00a0Cognitive Neuroscience. The Biology of the Mind. 4th ed., USA: W. W. Norton & Company, Inc; 2014."},{"issue":"6","key":"384_CR79","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/schbul\/sbs117","volume":"39","author":"RL Carhart-Harris","year":"2013","unstructured":"Carhart-Harris RL, et al. Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Schizophr Bull. 2013;39(6):1343\u201351.","journal-title":"Schizophr Bull"},{"issue":"1","key":"384_CR80","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/cercor\/bhab202","volume":"32","author":"P Duerler","year":"2021","unstructured":"Duerler P, et al. Psilocybin induces aberrant prediction error processing of tactile mismatch responses-a simultaneous EEG-FMRI study. Cereb Cortex. 2021;32(1):186\u201396.","journal-title":"Cereb Cortex"},{"key":"384_CR81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.neuro.31.060407.125618","volume":"32","author":"L Clark","year":"2009","unstructured":"Clark L, Chamberlain SR, Sahakian BJ. Neurocognitive mechanisms in depression: implications for treatment. Annu Rev Neurosci. 2009;32:57\u201374.","journal-title":"Annu Rev Neurosci"},{"issue":"11","key":"384_CR82","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/cns.12835","volume":"24","author":"FF Zhang","year":"2018","unstructured":"Zhang FF, et al. Brain structure alterations in depression: Psychoradiological evidence. CNS Neurosci Ther. 2018;24(11):994\u20131003.","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"384_CR83","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.biopsych.2006.09.020","volume":"62","author":"MD Greicius","year":"2007","unstructured":"Greicius MD, et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry. 2007;62(5):429\u201337.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"384_CR84","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/cns.12998","volume":"24","author":"BJ Li","year":"2018","unstructured":"Li BJ, et al. A brain network model for depression: From symptom understanding to disease intervention. CNS Neurosci Ther. 2018;24(11):1004\u201319.","journal-title":"CNS Neurosci Ther"},{"key":"384_CR85","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnhum.2014.00204","volume":"8","author":"L Roseman","year":"2014","unstructured":"Roseman L, et al. The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers. Front Hum Neurosci. 2014;8:204.","journal-title":"Front Hum Neurosci"},{"key":"384_CR86","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jad.2024.02.089","volume":"353","author":"D Copa","year":"2024","unstructured":"Copa D, et al. Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity. J Affect Disord. 2024;353:60\u20139.","journal-title":"J Affect Disord"},{"key":"384_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1133367","volume":"17","author":"J Schimmelpfennig","year":"2023","unstructured":"Schimmelpfennig J, et al. The role of the salience network in cognitive and affective deficits. Front Hum Neurosci. 2023;17:1133367.","journal-title":"Front Hum Neurosci"},{"issue":"2","key":"384_CR88","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.biopsych.2019.12.027","volume":"88","author":"KH Preller","year":"2020","unstructured":"Preller KH, et al. Psilocybin induces time-dependent changes in global functional connectivity. Biol Psychiatry. 2020;88(2):197\u2013207.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"384_CR89","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760\u201373.","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"384_CR90","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.biopsych.2013.02.026","volume":"74","author":"EV Sullivan","year":"2013","unstructured":"Sullivan EV, et al. A selective insular perfusion deficit contributes to compromised salience network connectivity in recovering alcoholic men. Biol Psychiatry. 2013;74(7):547\u201355.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"384_CR91","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nn1579","volume":"8","author":"BJ Everitt","year":"2005","unstructured":"Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005;8(11):1481\u20139.","journal-title":"Nat Neurosci"},{"issue":"11","key":"384_CR92","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrn3119","volume":"12","author":"RZ Goldstein","year":"2011","unstructured":"Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12(11):652\u201369.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"384_CR93","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1874473708666150107121331","volume":"7","author":"A Garcia-Romeu","year":"2015","unstructured":"Garcia-Romeu A, Griffiths RR, Johnson MW. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Curr Drug Abuse Rev. 2015;7(3):157\u201364.","journal-title":"Curr Drug Abuse Rev"},{"issue":"10","key":"384_CR94","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","volume":"79","author":"MP Bogenschutz","year":"2022","unstructured":"Bogenschutz MP, et al. Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial. JAMA Psychiat. 2022;79(10):953\u201362.","journal-title":"JAMA Psychiat"},{"issue":"4","key":"384_CR95","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41380-024-02632-3","volume":"30","author":"D Stoliker","year":"2025","unstructured":"Stoliker D, et al. Neural mechanisms of psychedelic visual imagery. Mol Psychiatry. 2025;30(4):1259\u201366.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"384_CR96","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.neuron.2011.09.006","volume":"72","author":"JD Power","year":"2011","unstructured":"Power JD, et al. Functional network organization of the human brain. Neuron. 2011;72(4):665\u201378.","journal-title":"Neuron"},{"issue":"1","key":"384_CR97","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/brain.2011.0019","volume":"1","author":"ME Raichle","year":"2011","unstructured":"Raichle ME. The restless brain. Brain Connect. 2011;1(1):3\u201312.","journal-title":"Brain Connect"},{"key":"384_CR98","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.neuroimage.2013.05.081","volume":"82","author":"X Shen","year":"2013","unstructured":"Shen X, et al. Groupwise whole-brain parcellation from resting-state fMRI data for network node identification. Neuroimage. 2013;82:403\u201315.","journal-title":"Neuroimage"},{"issue":"31","key":"384_CR99","doi-asserted-by":"publisher","first-page":"13040","DOI":"10.1073\/pnas.0905267106","volume":"106","author":"SM Smith","year":"2009","unstructured":"Smith SM, et al. Correspondence of the brain\u2019s functional architecture during activation and rest. Proc Natl Acad Sci U S A. 2009;106(31):13040\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"384_CR100","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuroimage.2013.05.041","volume":"80","author":"DC Van Essen","year":"2013","unstructured":"Van Essen DC, et al. The WU-Minn Human Connectome Project: an overview. Neuroimage. 2013;80:62\u201379.","journal-title":"Neuroimage"},{"key":"384_CR101","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1152\/jn.00338.2011","volume":"106","author":"BTT Yeo","year":"2011","unstructured":"Yeo BTT, et al. The organization of the human cortex estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106:1125\u201365.","journal-title":"J Neurophysiol"},{"issue":"1457","key":"384_CR102","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1098\/rstb.2005.1634","volume":"360","author":"CF Beckmann","year":"2005","unstructured":"Beckmann CF, et al. Investigations into resting-state connectivity using independent component analysis. Philos Trans R Soc Lond B Biol Sci. 2005;360(1457):1001\u201313.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"11","key":"384_CR103","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1007\/s00213-021-05915-7","volume":"239","author":"MAG Martens","year":"2022","unstructured":"Martens MAG, et al. Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder. Psychopharmacol. 2022;239(11):3447\u201360.","journal-title":"Psychopharmacol."},{"issue":"10","key":"384_CR104","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.euroneuro.2018.07.099","volume":"28","author":"A Schrantee","year":"2018","unstructured":"Schrantee A, et al. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity. Eur Neuropsychopharmacol. 2018;28(10):1173\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"384_CR105","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/02698811221125354","volume":"37","author":"ShukuroglouM","year":"2023","unstructured":"Shukuroglou M, et al. Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression. J Psychopharm. 2023;37(1):70\u20139. https:\/\/doi.org\/10.1177\/02698811221125354.","journal-title":"J Psychopharm"},{"key":"384_CR106","doi-asserted-by":"publisher","first-page":"117049","DOI":"10.1016\/j.neuroimage.2020.117049","volume":"220","author":"TF Varley","year":"2020","unstructured":"Varley TF, et al. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains. NeuroImage. 2020;220:117049.","journal-title":"NeuroImage"},{"issue":"7","key":"384_CR107","first-page":"681","volume":"9","author":"S Mortaheb","year":"2024","unstructured":"Mortaheb S, et al. Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024;9(7):681\u201392.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"4","key":"384_CR108","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41380-024-02632-3","volume":"30","author":"D Stroliker","year":"2025","unstructured":"Stroliker D, et al. Neural mechanisms of psychedelic visual imagery. Mol Psychiatry. 2025;30(4):1259\u201366.","journal-title":"Mol Psychiatry"}],"container-title":["Discover Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44192-026-00384-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44192-026-00384-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44192-026-00384-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:30:02Z","timestamp":1781641802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44192-026-00384-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1007\/s44192-026-00384-w","relation":{},"ISSN":["2731-4383"],"issn-type":[{"value":"2731-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this is a review article, it did not involve any collection or generation of new data from human nor animal research. Therefore, ethical approval was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}